RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion BPC 157 FDA Approval Unlikely Due to Patent Economics Stefano M. Sinicropi, MD posted on the topic LinkedIn FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Craze Ground Truths